Substance | Condition | Seq | Src | PMID | Dtl | Title |
Myricetin | Alzheimer's Disease | 5 | PM | 38423257 | 📋 | Protective Effects of Myricetin and Morin on Neurological Damage in Aβ1-42/Al3+ -induced Alzheimer's Disease Model of Rats |
Myricetin | Alzheimer's Disease | 4 | PM | 37086707 | 📋 | Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway |
Myricetin | Alzheimer's Disease | 3 | PM | 35114083 | 📋 | Myricetin Restores Aβ-Induced Mitochondrial Impairments in N2a-SW Cells |
Myricetin | Alzheimer's Disease | 2 | PM | 34560101 | 📋 | Myricetin slows liquid-liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity |
Myricetin | Alzheimer's Disease | 1 | PM | 34015458 | 📋 | Myricetin prevents high molecular weight Aβ 1-42 oligomer-induced neurotoxicity through antioxidant effects in cell membranes and mitochondria |
Myricetin | Amyotrophic Lateral Sclerosis | 1 | PM | 37314311 | 📋 | Myricetin: A Potent Anti-Amyloidogenic Polyphenol against Superoxide Dismutase 1 Aggregation |
Myricetin | Neurodegenerative Disease | 1 | PM | 32981207 | 📋 | The anti-STAT1 polyphenol myricetin inhibits M1 microglia activation and counteracts neuronal death |
Myricetin | Parkinson's Disease | 2 | PM | 35657723 | 📋 | Myricetin inhibits α-synuclein amyloid aggregation by delaying the liquid-to-solid phase transition |
Myricetin | Parkinson's Disease | 1 | PM | 33269757 | 📋 | Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells |